Machine Learning for Predicting Antibody Internalization Efficiency
Antibody-based therapeutics play a crucial role in treating cancers and autoimmune diseases. A key factor in their success is their ability to internalize into target cells, which influences delivery efficacy, especially in antibody-conjugates (ACs). Machine learning (ML) offers an approach to predicting antibody internalization efficiency based on molecular and cellular features. This paper explores ML applications in this area, focusing on data preprocessing, model selection, feature engineering, and evaluation metrics.